These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1548684)

  • 1. Perfluorocarbon-based antidiabetic agents.
    Kees KL; Smith TM; McCaleb ML; Prozialeck DH; Cheeseman RS; Christos TE; Patt WC; Steiner KE
    J Med Chem; 1992 Mar; 35(5):944-53. PubMed ID: 1548684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.
    Ellinboe JW; Alessi TR; Dolak TM; Nguyen TT; Tomer JD; Guzzo F; Bagli JF; McCaleb ML
    J Med Chem; 1992 Apr; 35(7):1176-83. PubMed ID: 1560432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.
    Malamas MS; Sredy J; McCaleb M; Gunawan I; Mihan B; Sullivan D
    Eur J Med Chem; 2001 Jan; 36(1):31-42. PubMed ID: 11231047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
    Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
    Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
    Wrobel J; Dietrich A; Woolson SA; Millen J; McCaleb M; Harrison MC; Hohman TC; Sredy J; Sullivan D
    J Med Chem; 1992 Nov; 35(24):4613-27. PubMed ID: 1469692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl)phenyl]alkanamides. A new class of oral antidiabetic agents.
    Kees KL; Cheeseman RS; Prozialeck DH; Steiner KE
    J Med Chem; 1989 Jan; 32(1):11-3. PubMed ID: 2642552
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Wyse BM; Gilchrist BJ
    Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice.
    Diani AR; Peterson T; Sawada GA; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
    Diabetologia; 1984 Aug; 27(2):225-34. PubMed ID: 6386585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents.
    Nomura M; Kinoshita S; Satoh H; Maeda T; Murakami K; Tsunoda M; Miyachi H; Awano K
    Bioorg Med Chem Lett; 1999 Feb; 9(4):533-8. PubMed ID: 10098657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on non-thiazolidinedione antidiabetic agents. 1. Discovery of novel oxyiminoacetic acid derivatives.
    Imoto H; Imamiya E; Momose Y; Sugiyama Y; Kimura H; Sohda T
    Chem Pharm Bull (Tokyo); 2002 Oct; 50(10):1349-57. PubMed ID: 12372861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.
    Zask A; Jirkovsky I; Nowicki JW; McCaleb ML
    J Med Chem; 1990 May; 33(5):1418-23. PubMed ID: 2329563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects.
    Shargill NS; Tatoyan A; Fukushima M; Antwi D; Bray GA; Chan TM
    Metabolism; 1986 Jan; 35(1):64-70. PubMed ID: 3510364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity.
    Pill J; Kühnle HF
    Metabolism; 1999 Jan; 48(1):34-40. PubMed ID: 9920142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
    Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
    J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciglitazone, a hypoglycemic agent: early effects on the pancreatic islets of ob/ob mice.
    Colca JR; Wyse BM; Sawada G; Jodelis KS; Connell CL; Fletcher-McGruder BL; Palazuk BJ; Diani AR
    Metabolism; 1988 Mar; 37(3):276-80. PubMed ID: 3278192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R; Kostyo JL; Colca JR
    Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.